dc.contributor.author | HARRIS, JAMES | |
dc.date.accessioned | 2011-02-15T18:23:08Z | |
dc.date.available | 2011-02-15T18:23:08Z | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010 | en |
dc.identifier.citation | James Harris, Joseph Keane, How tumour necrosis factor blockers interfere with tuberculosis immunity., Clinical and Experimental Immunology, 161, 1, 2010, 1 - 9 | en |
dc.identifier.other | Y | |
dc.description | PUBLISHED | en |
dc.description.abstract | Tumour necrosis factor (TNF) is a potent inflammatory cytokine that plays an important role in immunity to numerous bacterial infections, including Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB) in humans. Infliximab, adalimumab, certolizumab pegol and etanercept are anti-TNF agents used to treat a range of inflammatory/autoimmune diseases, such as rheumatoid arthritis. The use of some of these drugs has been linked to reactivation TB. In addition to blocking TNF-mediated immune responses, some anti-TNF drugs have been found to interfere with innate immune responses, such as phagolysosomal maturation and monocyte apoptosis, as well as cell-mediated responses, including interferon-? secretion by memory T cells, complement-mediated lysis of Mtb-reactive CD8+ T cells and increased regulatory T cell activity. This review summarizes some of the reported effects of TNF blockers on immune cell responses in the context of the observed clinical data on TB reactivation in patients on anti-TNF therapy. | en |
dc.description.sponsorship | Both authors are supported by Science Foundation Ireland (SFI) as part of the Immunology Research Centre, SFI Strategic Research Cluster. J. H. was supported in part by a grant from the Irish Lung Foundation. J. K. is funded by an HRB CSA award and the Royal City of Dublin Hospital Trust. | en |
dc.format.extent | 1 | en |
dc.format.extent | 9 | en |
dc.language.iso | en | en |
dc.publisher | John Wiley | en |
dc.relation.ispartofseries | Clinical and Experimental Immunology; | |
dc.relation.ispartofseries | 161; | |
dc.relation.ispartofseries | 1; | |
dc.rights | Y | en |
dc.subject | Immunology | en |
dc.subject | Mycobacterium tuberculosis | en |
dc.title | How tumour necrosis factor blockers interfere with tuberculosis immunity. | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/jaharris | |
dc.identifier.rssinternalid | 70987 | |
dc.identifier.rssuri | http://dx.doi.org/10.1111/j.1365-2249.2010.04146.x | en |
dc.identifier.uri | http://hdl.handle.net/2262/50589 | |